Literature DB >> 8929815

Minimally modified oligonucleotides - combination of end-capping and pyrimidine-protection.

A Peyman1, E Uhlmann.   

Abstract

The nuclease resistance of an oligonucleotide sequence that was phosphorothioate (PS)-modified in various positions and patterns was examined. We present a new ¿minimal' protection strategy for antisense oligonucleotides which is a combination of the end-capping technique and the protection of internal pyrimidine residues which are the major sites of endonuclease degradation. This strategy reduces the number of modifications needed to make a nuclease resistant oligonucleotide and therefore should minimize the non-sequence-specific effects that are frequently observed with uniformly modified oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929815     DOI: 10.1515/bchm3.1996.377.1.67

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  7 in total

1.  Design of antisense oligonucleotides stabilized by locked nucleic acids.

Authors:  Jens Kurreck; Eliza Wyszko; Clemens Gillen; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

2.  Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides.

Authors:  Hyunmin Kang; Michael H Fisher; Dong Xu; Yuko J Miyamoto; Arnaud Marchand; Arthur Van Aerschot; Piet Herdewijn; Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2004-08-17       Impact factor: 16.971

3.  Inhibition of human telomerase by 2'-O-methyl-RNA.

Authors:  A E Pitts; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

4.  Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.

Authors:  E M McGuffie; C V Catapano
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

Review 5.  Aptamers as theranostic agents: modifications, serum stability and functionalisation.

Authors:  Sarah Shigdar; Joanna Macdonald; Michael O'Connor; Tao Wang; Dongxi Xiang; Hadi Al Shamaileh; Liang Qiao; Ming Wei; Shu-Feng Zhou; Yimin Zhu; Lingxue Kong; Santanu Bhattacharya; ChunGuang Li; Wei Duan
Journal:  Sensors (Basel)       Date:  2013-10-10       Impact factor: 3.576

6.  Validation of miRNA-mRNA interactions by electrophoretic mobility shift assays.

Authors:  Anna Solé; Núria Mencia; Xenia Villalobos; Véronique Noé; Carlos J Ciudad
Journal:  BMC Res Notes       Date:  2013-11-12

Review 7.  Innovations in oligonucleotide drug delivery.

Authors:  Melanie A Lysik; Susanna Wu-Pong
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.